CONCEPTUS AND GYNECARE TERMINATE AGREEMENT

Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure(R) non-incisional permanent birth control system, today announced that effective immediately, Conceptus and Gynecare Worldwide, a division of Ethicon, Inc., have mutually agreed to terminate the exclusive co-promotion agreement entered into by the companies on October 30, 2003. Both companies believe that the relationship has been instrumental in educating physicians about the safety and efficacy of the concomitant use of the Essure device and the GYNECARE THERMACHOICE(a) Uterine Balloon Therapy System.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050805005241&newsLang=en)